Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation.
J Am Coll Cardiol. 2018.
PMID: 30049307
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 0 |
Search Results
5 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation.
J Am Coll Cardiol. 2018 Jul 31;72(5):477-485. doi: 10.1016/j.jacc.2018.04.084.
J Am Coll Cardiol. 2018.
PMID: 30049307
Free article.
BACKGROUND: Low-dose rivaroxaban (10 mg/day) has been widely used in Asia for patients with atrial fibrillation (AF), although there is a lack of evidence regarding its effectiveness. ...OBJECTIVES: The aim of this study was to evaluate t …
BACKGROUND: Low-dose rivaroxaban (10 mg/day) has been widely used in Asia for patients with atrial fibrillati …
Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis.
Eur J Clin Pharmacol. 2022 Feb;78(2):181-190. doi: 10.1007/s00228-021-03226-6. Epub 2021 Oct 15.
Eur J Clin Pharmacol. 2022.
PMID: 34651200
PURPOSE: Low-dose rivaroxaban is often given to patients with atrial fibrillation (AF) around the world, but the rationale for its use remains unclear. We aimed to compare the efficacy and safety of standard- or low-dose …
PURPOSE: Low-dose rivaroxaban is often given to patients with atrial fibrillation (AF) around the world, …
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation.
Chest. 2019 Sep;156(3):529-543. doi: 10.1016/j.chest.2019.04.108. Epub 2019 May 16.
Chest. 2019.
PMID: 31103697
BACKGROUND: Whether four direct oral anticoagulants (DOACs) are superior to warfarin in Asian patients with nonvalvular atrial fibrillation (NVAF) remains unclear. ...The effectiveness/safety outcomes with the four low-dose DOACs c …
BACKGROUND: Whether four direct oral anticoagulants (DOACs) are superior to warfarin in Asian patients with nonvalvular atrial …
A Combined Pharmacometrics Analysis of Biomarker Distribution Under Treatment With Standard- or Low-Dose Rivaroxaban in Real-World Chinese Patients With Nonvalvular Atrial Fibrillation.
Front Pharmacol. 2022 Mar 18;13:814724. doi: 10.3389/fphar.2022.814724. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35370683
Free PMC article.
Background: The rivaroxaban dose regimen for patients with nonvalvular atrial fibrillation (NVAF) is complex in Asia. ...Randomized studies should be performed to evaluate the efficacy and safety of low-dose rivaroxaban in Chinese …
Background: The rivaroxaban dose regimen for patients with nonvalvular atrial fibrillation (NVAF) is complex in Asia. . …
Outcomes After Use of Standard- and Low-Dose Non-Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation.
Stroke. 2019 Jan;50(1):110-118. doi: 10.1161/STROKEAHA.118.023093. Epub 2018 Dec 3.
Stroke. 2019.
PMID: 30580716
We tried to compare effectiveness and safety outcomes of standard- and low-dose NOACs and warfarin in this population. ...Conclusions- In this cohort of East Asian patients with nonvalvular atrial fibrillation, NOACs were as …
We tried to compare effectiveness and safety outcomes of standard- and low-dose NOACs and warfarin in thi …
Cite